Dr. Alejandra T. Perez, MD

Dr. Perez practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Perez's NPI, 1396731964, was assigned on September 20, 2005. Dr. Perez graduated from Institute of Health Sciences Medellin Faculty of Medicine in 1991. Dr. Perez holds Florida license 80220.

Dr. Perez's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Perez's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Perez to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Perez practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Perez's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Perez is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Perez's licenses on file in 2 states: Florida and Connecticut.

Dmand AI lists breast cancer and lung cancer among the conditions Dr. Perez treats.

CMS data shows 605 Medicare services from Dr. Perez across 3 procedure codes in 2024, all of them office visits, for 213 Medicare patients. Medicare paid $43,916 for them. Every service was in an office.

CMS counts 213 Medicare patients who saw Dr. Perez in 2024. The largest group is 65 to 74, with 108 patients. 75% of them have cancer, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Perez's median patient age at 67, with 94% women.

In 2024, Dr. Perez wrote 108 Medicare Part D claims for 52 patients. 99% of them were for generic drugs. CMS names the drug for 50 of them, across 3 drugs with 11 or more claims each, at $526 in total drug cost. In 2023, CMS named 87 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Perez for performance year 2024, reported as part of a group. Dr. Perez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Perez as offering telehealth.

Dmand AI links 7 papers to Dr. Perez, published from 2017 to 2025. The most frequent topics are Breast Neoplasms, Carcinoma, Ductal, Breast and Neoadjuvant Therapy. Dr. Perez has published most often in Breast Cancer Res Treat. Dr. Perez's most frequent co-authors are Alejandra Perez, MD, Jose Ramon Alvarez, FCCP, MD and Banu K. Arun, MD.

CMS Open Payments shows 83 general payments to Dr. Perez from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 79% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,555.

Dr. Perez graduated from Institute of Health Sciences Medellin Faculty of Medicine in 1991.

Dr. Perez is in network with 10 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.